The Role of GLP-1 in Cardiovascular Health and Calorie Needs
Understanding GLP-1 and its Impact on Cardiovascular Health
Glucagon-like peptide-1 (GLP-1) receptor agonists have been well-established drugs for the treatment of type 2 diabetes (T2D) for several years. Beyond their glycemic control benefits, GLP-1 receptor agonists have shown significant beneficial effects on cardiovascular health. These medications act by binding to GLP-1 receptors, which are widely distributed in the body, including cardiomyocytes and blood vessels. Research has demonstrated that GLP-1 receptor agonists can reduce the risk of major adverse cardiovascular events, cardiovascular mortality, and heart failure events.The Role of GLP-1 in Calorie Needs
